CompletedPhase 3

Hip Denervation and Intra-articular Hydration in Damaged Hip in Axial Spondyloarthritis Patients

Egypt60 participantsStarted 2021-12-01

Plain-language summary

Background: The hip joint is frequently affected in axial spondyloarthritis (SpA) of adults with destructive effects in untreated patients. About 35% of axial SpA patients had either unilateral or bilateral hip arthritis. Destruction is more common with early-onset, active disease, or enthesitis. Objectives: The aim of this study is to evaluate the effect of hip denervation (HD) and intra-articular hydration (IAH) on pain, function score, hip mobility scores in a cohort of axial SpA patients with grade 3 and 4 hip BASRI scores.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * age 18 or more * Axial; SpA fulfilled ASA criteria * BASRI score grade 3 or 4 for one hip at least Exclusion Criteria: * patients younger than 18 * Axial; SpA with normal hip or hip involvement less than 3 on BASRI score

What they're measuring

Change in visual analogue scale

Timeframe: Baseline , after 4 weeks and after 12 weeks

Change in Harris functional hip score

Timeframe: Baseline, after 4 weeks and after 12 weeks

Change in range of motion of the hip

Timeframe: Baseline, after 4 weeks and after 12 weeks

Change in semiquantitative tenderness score

Timeframe: Baseline, after 4 weeks and after 12 weeks

Trial details

NCT IDNCT05219084

SponsorSohag University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-04-15

View on ClinicalTrials.gov More Patients With Axial SpA According to ASAS Criteria trials